Search

Your search keyword '"Bauer, Michelle J."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Bauer, Michelle J." Remove constraint Author: "Bauer, Michelle J." Search Limiters Full Text Remove constraint Search Limiters: Full Text
36 results on '"Bauer, Michelle J."'

Search Results

2. Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

3. Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis

4. The Genomic Epidemiology of Clinical Burkholderia pseudomallei Isolates in North Queensland, Australia.

5. Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis

9. Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular Applications

10. Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints

11. Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model

15. Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection

16. Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131

17. Genomic analysis of Elizabethkingia species from aquatic environments: Evidence for potential clinical transmission

20. Optimising Treatment Outcomes for Children and Adults Through Rapid Genome Sequencing of Sepsis Pathogens. A Study Protocol for a Prospective, Multi-Centre Trial (DIRECT)

22. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC β-Lactamase–producing enterobacter spp, citrobacter freundii, morganella morganii, providencia spp, or serratia marcescens: A pilot multicenter randomized controlled trial (MERINO-2)

23. Optimising Treatment Outcomes for Children and Adults Through Rapid Genome Sequencing of Sepsis Pathogens. A Study Protocol for a Prospective, Multi-Centre Trial (DIRECT)

24. Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains.

28. Evaluation of Skin Colonisation And Placement of vascular access device Exit sites (ESCAPE Study).

30. Conjugative transfer of ICESde3396 between three β-hemolytic streptococcal species.

31. Genomic analysis of Elizabethkingiaspecies from aquatic environments: Evidence for potential clinical transmission

32. Laboratory Safety: Handling Burkholderia pseudomalleiIsolates without a Biosafety Cabinet

33. Burkholderia pseudomalleiClinical Isolates Are Highly Susceptible In Vitroto Cefiderocol, a Siderophore Cephalosporin

34. Genomic analysis of Elizabethkingia species from aquatic environments: Evidence for potential clinical transmission

35. Genomic analysis of Elizabethkingia species from aquatic environments: Evidence for potential clinical transmission.

36. Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii , Morganella morganii , Providencia spp, or Serratia marcescens : A Pilot Multicenter Randomized Controlled Trial (MERINO-2).

Catalog

Books, media, physical & digital resources